Genetic Stabilization of Transthyretin, Cerebrovascular Disease, and Life Expectancy

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  2013-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/ATVBAHA.113.301273PMID 23580146
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Senile systemic amyloidosis].

  2014cited by this paper
• Age-related oxidative modifications of transthyretin modulate its amyloidogenicity.

  2013cited by this paper
• 25‐Hydroxyvitamin D and symptomatic ischemic stroke: An Original Study and Meta‐Analysis

  2013cited by this paper
• Dietary curcumin counteracts extracellular transthyretin deposition: insights on the mechanism of amyloid inhibition.

  2013cited by this paper
• Green tea halts progression of cardiac transthyretin amyloidosis: an observational report

  2012cited by this paper
• Tafamidis for transthyretin familial amyloid polyneuropathy

  2012cited by this paper
• The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug.

  2012cited by this paper
• Arterial thromboembolism in senile systemic amyloidosis: report of two cases

  2012cited by this paper
• Epigallocatechin-3-Gallate as a Potential Therapeutic Drug for TTR-Related Amyloidosis: “In Vivo” Evidence from FAP Mice Models

  2012cited by this paper
• Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade

  2012cited by this paper
• Cardiac amyloidosis.

  2012cited by this paper
• Cardiac Amyloidosis: A Treatable Disease, Often Overlooked

  2011cited by this paper
• Transthyretin and the brain re-visited: Is neuronal synthesis of transthyretin protective in Alzheimer's disease?

  2011cited by this paper
• Mechanisms of transthyretin cardiomyocyte toxicity inhibition by resveratrol analogs.

  2011cited by this paper
• Sterol transporter adenosine triphosphate–binding cassette transporter G8, gallstones, and biliary cancer in 62,000 individuals from the general population

  2011cited by this paper
• CSF transthyretin neuroprotection in a mouse model of brain ischemia

  2010cited by this paper
• Transthyretin: more than meets the eye.

  2009cited by this paper
• A new equation to estimate glomerular filtration rate.

  2009cited by this paper
• Perflint: A Context Sensitive Performance Advisor for C++ Programs

  2009cited by this paper
• Iodine Atoms: A New Molecular Feature for the Design of Potent Transthyretin Fibrillogenesis Inhibitors

  2009cited by this paper
• Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Aβ toxicity

  2008cited by this paper
• Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2‐macroglobulin and tau: A population‐based autopsy study

  2008cited by this paper
• Early cardiac involvement in senile systemic amyloidosis: a case report

  2008cited by this paper
• Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease.

  2008cited by this paper
• Transthyretin enhances nerve regeneration

  2007cited by this paper
• MCSTL: the multi-core standard template library

  2007cited by this paper
• Universal definition of myocardial infarction.

  2007cited by this paper
• Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology.

  2006cited by this paper
• Guidelines on the management of stable angina pectoris: executive summary: the task force on the management of stable angina pectoris of the European society of cardiology.

  2006cited by this paper
• A clinico-pathologic correlation.

  2005cited by this paper
• The biological and chemical basis for tissue-selective amyloid disease.

  2005cited by this paper
• The Metabolic and Molecular Bases of Inherited Disease (Scriver, C. R., Beaudet, A. L., Sly, W. S., Valle, D., Childs, B., Kinzler, K. W., and Vogelstein, B., eds., 8th ed., McGraw-Hill, New-York, 2001, 7012 p., $550.00)

  2004cited by this paper
• Transthyretin-derived senile systemic amyloidosis: clinicopathologic and structural considerations

  2003cited by this paper
• Prevention of Transthyretin Amyloid Disease by Changing Protein Misfolding Energetics

  2003cited by this paper
• Sporadic and Familial Cerebral Amyloid Angiopathies

  2002cited by this paper
• Identification of a novel transthyretin Thr59Lys/Arg104His. A case of compound heterozygosity in a Chinese patient diagnosed with familial transthyretin amyloidosis

  2002cited by this paper
• The Metabolic and Molecular Bases of Inherited Disease

  2001cited by this paper
• Trans-Suppression of Misfolding in an Amyloid Disease

  2001cited by this paper
• Cerebral amyloid angiopathy: An overview

  2000cited by this paper
• Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

  2000cited by this paper
• The Thyroxine-Binding Proteins

  2000cited by this paper
• Comparative studies of two transthyretin variants with protective effects on familial amyloidotic polyneuropathy: TTR R104H and TTR T119M.

  2000cited by this paper
• Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

  2000cited by this paper
• Reference distributions for the negative acute‐phase serum proteins, albumin, transferrin and transthyretin: A practical, simple and clinically relevant approach in a large cohort

  1999cited by this paper
• A novel compound heterozygote (FAP ATTR Arg104His/ATTR Val30Met) with high serum transthyretin (TTR) and retinol binding protein (RBP) levels.

  1999cited by this paper
• The systemic amyloidoses.

  1998cited by this paper
• The systemic amyloidoses.

  1997cited by this paper
• Thyroxine binding to transthyretin Met 119. Comparative studies of different heterozygotic carriers and structural analysis.

  1997cited by this paper
• Comparative stability and clearance of [Met30]transthyretin and [Met119]transthyretin.

  1997cited by this paper
• Inhibiting transthyretin amyloid fibril formation via protein stabilization.

  1996cited by this paper
• Case report.

  1995cited by this paper
• Thyroxine binding by human transthyretin variants: mutations at position 119, but not position 54, increase thyroxine binding affinity.

  1994cited by this paper
• Transthyretin sequesters amyloid beta protein and prevents amyloid formation.

  1994cited by this paper
• Thyroxine binding in a TTR Met 119 kindred.

  1993cited by this paper
• Biochemical and clinical characterization of prealbuminCHICAGO: an apparently benign variant of serum prealbumin (transthyretin) discovered with high-resolution two-dimensional electrophoresis.

  1991cited by this paper
• Fibril in senile systemic amyloidosis is derived from normal transthyretin.

  1990cited by this paper
• Transthyretin

  1986cited by this paper
• Senile systemic amyloidosis.

  1984cited by this paper
• Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation.

  1983cited by this paper
• [Thyroxine-binding proteins].

  1968cited by this paper
• A REPORT OF TWO CASES

  1923cited by this paper

• ABCC6 Heterozygosity as Genetic Predisposition to Cerebrovascular Disease Across Ages.

  2026cites this paper
• Circulating transthyretin with atrial morpho-functional phenotypes and atrial fibrillation risk, and the modifying role of BMI

  2025cites this paper
• Serum Transthyretin as Prognostic Biomarker for Cardiovascular Events and Mortality

  2025cites this paper
• Advances in Cardiovascular Pharmacotherapy. V. Molecular Targets in Transthyretin Amyloid Cardiomyopathy.

  2025cites this paper
• Unravelling the myriad physiologic roles of transthyretin: critical considerations for treating transthyretin amyloidosis

  2025cites this paper
• Tailored therapeutics for cardiomyopathies

  2025cites this paper
• Biomarkers in Subclinical Transthyretin Cardiac Amyloidosis

  2025cites this paper
• Differential Binding Affinities and Kinetics of Transthyretin Stabilizers

  2025cites this paper
• Evolving Strategies in Cardiac Amyloidosis: From Mechanistic Discoveries to Diagnostic and Therapeutic Advances.

  2024cites this paper
• Unfolding the Link Between Transthyretin Stability and Survival.

  2024cites this paper
• Transthyretin Tetramer Destabilization and Increased Mortality in the General Population.

  2024cites this paper
• Cardiac Amyloidosis: State-of-the-Art Review in Molecular Pathology

  2024cites this paper
• Hereditary Transthyretin Amyloidosis Polyneuropathy

  2024cites this paper
• Clinical Use of Biomarkers in Cardiac Amyloidosis.

  2024cites this paper
• Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy.

  2024cites this paper
• Tafamidis concentration required for transthyretin stabilisation in cerebrospinal fluid

  2023cites this paper
• Emerging therapeutic Avenues in cardiac amyloidosis.

  2023cites this paper
• Update on Disease-Specific Biomarkers in Transthyretin Cardiac Amyloidosis

  2022cites this paper
• Advances in the treatment of transthyretin cardiac amyloidosis: Current and emerging therapies

  2021cites this paper
• Does protein aggregation drive postmitotic tissue degeneration?

  2021cites this paper
• Neuroprotection in early stages of Alzheimer’s disease is promoted by transthyretin angiogenic properties

  2021cites this paper
• Use of biomarkers to diagnose and manage cardiac amyloidosis

  2021cites this paper
• Molecular Mechanisms of Cardiac Amyloidosis

  2021cites this paper
• A Narrative Review of the Role of Transthyretin in Health and Disease

  2020cites this paper
• Hereditary transthyretin amyloidosis

  2020cites this paper
• Undiscovered Roles for Transthyretin: From a Transporter Protein to a New Therapeutic Target for Alzheimer’s Disease

  2020cites this paper
• Disease-Specific Biomarkers in Transthyretin Cardiac Amyloidosis

  2020cites this paper
• Transthyretin-stabilising mutation T119M is not associated with protection against vascular disease or death in the UK Biobank

  2020influential citation
• Molecular Imaging of Cardiac Amyloidosis

  2020cites this paper
• Subclinical retinal angiopathy associated with hereditary transthyretin amyloidosis – assessed with optical coherence tomography angiography

  2020cites this paper
• The inhibition of cellular toxicity of amyloid-β by dissociated transthyretin

  2020cites this paper
• Misfolded Transthyretin as a Novel Risk Factor for Heart Failure: A Rich History With Implications for Future Diagnosis and Treatment.

  2020cites this paper
• Association of Low Plasma Transthyretin Concentration With Risk of Heart Failure in the General Population.

  2020cites this paper
• Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy.

  2019influential citation
• The inhibition of cellular toxicity of amyloid-beta by dissociated transthyretin

  2019cites this paper
• Transthyretin-stabilizing mutation T119M is not associated with protection against vascular disease or death in the UK Biobank

  2019influential citation
• Drivers of α-sheet formation in transthyretin under amyloidogenic conditions.

  2019cites this paper
• Genetic Support for Longevity-Enhancing Drug Targets: Issues, Preliminary Data, and Future Directions.

  2019cites this paper
• The potency of AG10 in stabilizing transthyretin is driven by interactions mimicking the disease-suppressing T119M variant

  2019cites this paper
• First‐in‐Human Study of AG10, a Novel, Oral, Specific, Selective, and Potent Transthyretin Stabilizer for the Treatment of Transthyretin Amyloidosis: A Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Healthy Adult Volunteers

  2019cites this paper
• Trends and causes of hospitalizations in patients with amyloidosis

  2019cites this paper
• Enthalpy-Driven Stabilization of Transthyretin by AG10 Mimics a Naturally Occurring Genetic Variant That Protects from Transthyretin Amyloidosis.

  2018cites this paper
• Insights on the Interaction between Transthyretin and Aβ in Solution. A Saturation Transfer Difference (STD) NMR Analysis of the Role of Iododiflunisal.

  2017cites this paper
• Transthyretin stability is critical in assisting beta amyloid clearance– Relevance of transthyretin stabilization in Alzheimer's disease

  2017cites this paper
• The prevalence and distribution of the amyloidogenic transthyretin (TTR) V122I allele in Africa

  2016cites this paper
• Modulating Role of TTR in Aβ Toxicity, from Health to Disease

  2016cites this paper
• Can Super-Duper Centenarians Possibly Matter? Increasingly It Seems They May

  2015cites this paper
• The Diversity of Mechanisms Influenced by Transthyretin in Neurobiology: Development, Disease and Endocrine Disruption

  2015cites this paper
• Targeting protein aggregation for the treatment of degenerative diseases

  2015cites this paper
• Transthyretin: a multifaceted protein

  2014cites this paper
• Rzadkie – monogenetyczne – przyczyny udaru mózgu związanego z małymi naczyniami

  2014cites this paper
• [Update on the genetics of stroke].

  2014cites this paper
• Transthyretin Stabilization by Iododiflunisal Promotes Amyloid-β Peptide Clearance, Decreases its Deposition, and Ameliorates Cognitive Deficits in an Alzheimer's Disease Mouse Model

  2014cites this paper
• Quantification of Transthyretin Kinetic Stability in Human Plasma Using Subunit Exchange

  2014cites this paper
• A network-based analysis of ischemic stroke using parallel microRNA-mRNA expression profiles

  2014cites this paper
• Is the prevalent human prion protein 129M/V mutation a living fossil from a Paleolithic panzootic superprion pandemic?

  2014cites this paper
• Search for early TTR-related biomarkers in a transgenic AD mouse model

  2013cites this paper